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Abstract: Autophagy is an essential cellular homeostatic mechanism by which intracellular components 
are delivered into the lysosomes for degradation and recycling. Autophagy has been related with a 
diversity of pathological or physiological dentary processes such as bone remodeling, skeletal aging, 
osteoclastogenesis, osteoblastogenesis and different types of oral cancer. Platelet-rich plasma (PRP), 
isolated from autologous blood, is a plasma preparation containing a higher concentration of platelets 
which contains numerous different growth factors and cytokines that activate several cellular signaling 
cascades. The purpose of this study is to investigate the effect of PRP on autophagy stimulation in 
both osteoblast precursor 3T3-L1 and non-related osteoblastic cells. Our results showed that PRP 
can increase the number of autophagic structures in 3T3-L1 and HeLa (cervical cancer cells) cells. 
Moreover, we have determined by Western blot a rise in the lipidated form of the autophagic protein 
LC3 (i.e. LC3-II) upon PRP treatment. Taken together, our results suggest that PRP is able to induce a 
strongly autophagy response in osteoblast precursor and, to a lesser extent, in non-related osteoblastic 
cells, suggesting that PRP could be a potential therapeutic tool for some autophagy-related diseases 
associated with bone homeostasis.
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Bone homeostasis is a tightly controlled mechanism in which 
osteoblasts (OB,  the cells responsible for bone formation), 
osteoclasts (OC, the cells specialized for bone resorption) 
and osteocytes (the multifunctional mechanosensing cells 
embedded in the bone matrix), are the main actors in bone 
remodeling (Raggatt et al., 2010). 
Osteoblast and adipocytes are originated from common 
mesenchymal stem cells (MSCs), and several transcription 
factors control the differentiation of the two lineages (Kandel 
et al., 1999;  Prockop, 1997). Other reports have shown that 
3T3-L1 cells, an immortalized preadipocyte cell line (Green 
et al., 1974), are able to differentiate into bone-forming 
osteoblasts by transdifferentiation. This differentiation 
produces an increase of alkaline phosphatase (ALP) activity 
and expression of  osteocalcin (OC), bone sialoprotein (BSP), 
and osterix (Osx) with the formation of mineralized matrix 
(Justesen et al., 2004; Xie et al., 2014; Takahashi, 2011). 
These data indicate that 3T3-L1 cells are a good model to 
study the molecular mechanisms of osteoblast function and 
differentiation. 
Macroautophagy (hereafter, autophagy) is a lysosomal 
catabolic event which is implicated in the turnover and 
clearance of cytoplasmic components in healthy and damaged 
tissue via a lysosomal pathway (Eskelinen et al., 2009; 
Knecht et al., 2009; Mizushima et al., 2008). This process 
has been involved in tissue regeneration and recycling of 
key molecules in cell metabolism. Autophagy has been 
related with a diversity of physiological processes such as 
innate and adaptive immunity, inflammation, apoptosis, cell 
differentiation and maturation, thus potentially influencing 
the associated pathological processes. Moreover, several 
works have indicated the important role of autophagy in bone 
homeostasis. It has been reported that autophagy suppression 
in osteocytes produces a diminishment in bone mass and 
bone turnover in mice, resulting in an aging-like process 
in bone tissue and skeleton (Onal et al., 2013). Moreover, 
several studies have demonstrated that impaired autophagy 
in osteoblast leads to an osteoporotic-like phenotype (Onal 
et al., 2013; Nollet et al., 2014). A recent study has shown 
that Atg7 is needed during osteoblastic cell differentiation, 
indicating the important role of autophagy in this process 
(Ozeki et al., 2016). Moreover, genetic or pharmacological 
inhibition of autophagy suppresses mesenchymal stem cell 
differentiation to OB. Moreover, autophagy inhibition in 
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osteocytes results in a reduced bone volume (Onal et al., 
2013). Furthermore, autophagy inhibition leads to a severe 
decrease in the efficiency of OB function in vitro (DeSelm 
et al., 2011; Chung et al., 2012). In addition, several works 
have shown a link between autophagy and some secretion 
processes, where one of the OB functions is the extracellular 
matrix production (Manjithaya et al., 2011; Deretic et al., 
2012; Nollet et al., 2014). In this context, autophagy has 
another crucial role in the control of the OB to OC cell ratio, 
and therefore, in bone remodeling, regulating the bone cell 
survival/apoptosis (Nollet et al., 2014).
FIGURE 1. PRP induces autophagy in 3T3-L1 and HeLa cells. 3T3-L1 or HeLa cells were incubated in D-MEM medium with 
10% bovine fetal serum at 37°C and 5% CO2. Then, cells were transfected with GFP-LC3 and 24 h later incubated in absence (Ctr) or 
presence of 10 µl of PRP or 50 µM of resveratrol (Positive control) for 4 h at 37°C. (A) Images were obtained by confocal microscopy. (B) 
The percentage of LC3-positive vesicles was measured from images as those displayed in (A).
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FIGURE 2. Western blot analysis. (A) Samples were subjected 
to SDS-PAGE and transferred onto a nitrocellulose membrane. 
The membrane was incubated with a mouse anti-LC3 and the 
corresponding horseradish peroxidase (HRP)-labeled secondary 
antibodies and subsequently developed with an enhanced 
chemiluminescence detection kit. (B) Quantifications of relative optic 
density (arbitrary units) were made using ImageJ software. 
Platelet-rich plasma (PRP), isolated from autologous 
blood, is a plasma preparation containing a higher 
concentration of platelets (Everts et al., 2006; Marx, 2004). 
The platelets secrete multiple kinds of growth factors such as 
platelet-derived growth factor (PDGF), insulin-like growth 
factor (IGF), transforming growth factor 𝛽 (TGF-𝛽), basic 
fibroblast growth factor, and vascular endothelial growth 
factor (Xie et al., 2014; Foster et al., 2009), which provide 
unique abilities to promote wound healing and enhance 
osteogenesis. Due to the repertoire of cytokines, PRP might 
accelerate different biological processes such as endothelial, 
epithelial and epidermal regeneration, enhancement 
of collagen synthesis, stimulation of angiogenesis and 
enhancement of the hemostatic response to injury. For this 
reason, PRP has an extremely broad range of clinical healing 
applications in head, neck, oral and maxillofacial surgery as 
well periodontics among others (Smith et al., 2007; Laudy et 
al., 2015). Interestingly, a very recent report has shown that 
PRP exhibits a chondroprotective effect via the modulation 
of autophagy in chondrocytes, suggesting that PRP is able to 
induces autophagy in some cell types (Yang et al., 2018). In this 
context, the present report aimed to show whether PRP was 
able to induce autophagy in osteoblast precursors 3T3-L1 cells.
In this experiment, PRP was prepared from 5 ml of 
whole blood from a forty years old male. Blood coagulation 
was inhibited by the addition of 3.8% sodium citrate. The 
anticoagulated blood was centrifuged at a speed of 1000 rpm 
for 10 min. The top plasma layer was carefully collected and 
then centrifuged at a speed of 3000 rpm for 10 min. The 
supernatant was discarded, and precipitated platelets were 
resuspended to obtain 1 ml of PRP. Thrombin (1000 U in 10% 
CaCl2; 9:1) was added to PRP and then incubated at 37°C in a 
humidified atmosphere containing 5% CO2 for 30 min. After 
incubation, the sample was centrifuged at 4000 rpm.
In order to address whether PRP was able to induce 
autophagy, embryonic rat cells (3T3-L1) or fibroblastic 
human cancer cells (HeLa) were grown in glass coverslips 
in 6-well dishes and incubated in D-MEM medium 
supplemented with 10% bovine fetal serum, at 37°C and 5% 
CO2. Then, cells were transfected with the autophagosomal 
marker protein GFP-LC3 and were incubated 24h later, 
either in absence (Ctr) or presence of 10 µl of PRP or 50 
µM of resveratrol (an autophagy inductor) for 4 h at 37°C. 
A population of each cell type was analyzed by confocal 
microscopy. Interestingly, 3T3-L1 cells incubated in the 
presence of PRP presented an increased number of GFP-LC3 
structures (autophagic vesicles), compared with the control 
condition (Fig. 1A). PRP also induced autophagy in HeLa 
cells to a lesser extent than in 3T3-L1 (Fig. 1A). The number 
of GFP-LC3 positive structures was quantified (Fig. 1B). 
Autophagy stimulation causes an increased amount of 
the lipidated LC3 form that can be assessed by Western blot 
(Tanida et al., 2005). Thus, the level of processed LC3-II form 
was analyzed in cells incubated in the conditions mentioned 
before. As expected, an increased amount of the LC3-II form 
was observed in both HeLa and 3T3-L1 cells incubated in the 
presence PRP, being the level of lipidated LC3 lesser in HeLa 
cells than in 3T3-L1 cells (Figs. 2A and 2B). Taken together, 
our results suggest that PRP induces a stronger autophagy 
process in 3T3-L1 cells than in HeLa cells.
Bone regeneration requires the complex and well-
organized process of bone formation (Dimitriou et al., 2011). 
Several works have shown that autophagy plays an important 
role in bone cells, participating in both bone homeostasis and 
bone cell differentiation (Hocking et al., 2012). Our results 
showed that PRP is able to induce autophagy, increasing the 
number of autophagic structures and the level of lipidated 
LC3 in osteoblast precursor cells and non-related osteoblastic 
cells. In agreement with our results, another two groups have 
shown that PRP can stimulate autophagy in chondrocytes, 
contributing to cartilage repair and regeneration (Moussa 
et al., 2017; Yang et al., 2018). These data allow us to 
speculate that autophagy induction by PRP could favor the 
differentiation or functionality of the osteoblast precursors.
In clinical fields, bone tissue regeneration has been a 
crucial part of regenerative medicine, where PRP has been 
widely used in orthopedics, dental, periodontal, cosmetic 
and maxillofacial surgery due to its beneficial effects in 
tissue repairment (Kon et al., 2009; Lopez-Vidriero et al., 
2010; Caramés et al., 2010, 2015). As mentioned before, 
autophagy has been related with a diversity of physiological 
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processes such as formation of mineralized matrix, where 
its perturbation can lead to many pathologies including 
osteoporosis and osteoarthrit is .  For these reasons, 
understanding the action of autophagy modulators such 
as PRP, could lead to feasible, new therapeutic approaches 
against bone disease.
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